CLINICAL_TRIALS
trial_result
· 2013-02-28
Clinical Trial Update: CP-751,871 Treatment For Patients With Multiple Myeloma [Phase 1]
Summary
A Phase 1 trial of CP-751,871 in patients with multiple myeloma has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2013-02-28